LEGN
Legend Biotech Corp
18.60$
-2.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +79.7% | -32.9% | +151.0% | +55.0% | +18.9% | +38.9% | -9.7% | +3.8% | |
| – | +41.6% | -36.7% | +186.8% | +59.9% | +15.7% | +36.3% | -14.3% | -2.9% | |
| – | +9,836.9% | -60.3% | +447.1% | +51.1% | +14.1% | +62.6% | -77.6% | +214.5% | |
| – | +10,121.3% | -26.5% | +218.4% | +74.4% | +16.2% | +27.6% | -14.2% | -15.5% | |
| – | -52.5% | -67.1% | +131.0% | -29.1% | -24.0% | +252.8% | -20.5% | +100.4% | |
| – | +10,218.2% | +1.9% | +55.6% | -2.8% | +492.0% | +87.7% | +23.0% | +33.9% | |
| – | +988.7% | +149.1% | +52.5% | +26.3% | +5.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +2,350.0% | +10,408.2% | -44.6% | +489.2% | +308.7% | -94.1% | +4,190.2% | -57.2% | |
| – | +85.6% | -2.3% | -70.2% | +189.1% | +65.9% | +1.8% | +5.4% | +16.2% | |
| – | +205.4% | -19.7% | -9.5% | +98.3% | +29.9% | -27.3% | +28.3% | +129.2% | |
| – | +482.8% | +175.3% | +74.4% | -49.1% | +291.1% | -10.9% | +51.0% | +6,710.6% | |
| – | +68.9% | +31.0% | -48.8% | +43.4% | +350.0% | -36.4% | +84.5% | +118.3% | |
| – | – | – | – | – | +116.6% | +7.8% | +7.1% | – | |
| – | -28.9% | -1,520.6% | – | +28.1% | -2.8% | +68.1% | -16.8% | -3.7% | |
| – | -32.9% | -2,336.9% | – | – | – | – | – | – | |
| – | -24.1% | +31.7% | -10.5% | +19.2% | +12.9% | +10.7% | +3.8% | +0.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.